Evidence map›Paper›PMID 40681674›Full record

ArticleNature medicine2025

Data governance must consider the interests of the global community.

Jon Rueda, Sebastian Porsdam Mann, Janet Delgado, Brian D Earp, Karin Jongsma, Heidi Mertes, Davide Battisti, Íñigo de Miguel Beriain, Gabriela Lenarczyk, Vera Lúcia Raposo and 5 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Nature medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Jon RuedaPresident's Cabinet, Spanish National Research Council, Madrid, Spain. jon.rueda@csic.es.ORCID http://orcid.org/0000-0001-5789-7515
Sebastian Porsdam MannCenter for Advanced Studies in Bioscience Innovation Law (CeBIL), Faculty of Law, University of Copenhagen, Copenhagen, Denmark.
Janet DelgadoSchool of Health Sciences, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
Brian D EarpCentre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Karin JongsmaJulius Center, Department of Bioethics & Health Humanities, University Medical Center Utrecht, Utrecht, the Netherlands.ORCID http://orcid.org/0000-0001-8135-6786
Heidi MertesDepartment of Philosophy and Moral Sciences, Ghent University, Ghent, Belgium.
Davide BattistiInterdepartmental Center for Research Ethics and Integrity (CID Ethics), National Research Council of Italy (CNR), Rome, Italy.
Íñigo de Miguel BeriainIkerbasque, Basque Foundation for Science, Bilbao, Spain.
Gabriela LenarczykCenter for Advanced Studies in Bioscience Innovation Law (CeBIL), Faculty of Law, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0001-5965-7291
Vera Lúcia RaposoNOVA School of Law, CEDIS-Research & Development Centre on Law and Society, Universida de Nova de Lisboa, Lisbon, Portugal.ORCID http://orcid.org/0000-0001-7895-2181
Robert RanischFaculty of Health Sciences Brandenburg, University of Potsdam, Potsdam, Germany.
Murilo VilaçaOswaldo Cruz Foundation, National School of Public Health, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0001-9720-5552
Tomasz ŻuradzkiInstitute of Philosophy, Jagiellonian University in Kraków, Kraków, Poland.ORCID http://orcid.org/0000-0001-6749-2124
David Rodríguez-AriasCátedra Youngner de Bioética Empírica, FiloLab-UGR, Department of Philosophy I, University of Granada, Granada, Spain.ORCID http://orcid.org/0000-0002-4555-5259
Angel PuyolDepartment of Philosophy, Universitat Autònoma de Barcelona, Barcelona, Spain.

Funding

EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 805498EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 919841-DIMEEC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 101137423EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) No. 101137423Eusko Jaurlaritza (Basque Government) IT 1541-22Ministry of Economy and Competitiveness | Agencia Estatal de Investigación (Spanish Agencia Estatal de Investigación) PID2023-148517NB-100National Research Foundation Singapore (National Research Foundation-Prime Minister's office, Republic of Singapore) AISG3-GV-2023-012Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Netherlands Organisation for Scientific Research) VI.Vidi.221F.010Novo Nordisk Fonden (Novo Nordisk Foundation) NNF23SA0087056Volkswagen Foundation (VolkswagenStiftung) 9B233
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40681674

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.